VS
Umoja Biopharma logo

Umoja Biopharma

Pioneering advanced immunotherapies to empower the body's innate ability to fight cancer by reengineering immune cells directly within the patient.

9 employees · est. 2019

Mana Therapeutics is the older company (2018 vs 2019).

Side-by-Side Comparison

Mana Therapeutics Umoja Biopharma
Founded
2018 older 2019
Headquarters
Not tracked yet Not tracked yet
Employees
Not tracked yet 9
Industry
Biotechnology Biopharma, Biotechnology, Information Technology
Funding Stage
Debt Financing Series C
Total Funding
$49.50M $363.00M
Funding Rounds
4 5
Services
Not tracked yet Development of in vivo CAR T cell therapies, In-house manufacturing of CAR T therapeutics, Pipeline focusing on cancer treatments
Target Customers
Not tracked yet Cancer patients, Healthcare providers, Medical researchers
Taxonomy
Not tracked yet Immunotherapy, Cancer Treatment, Biopharmaceutical, In Vivo Immune Engineering, Immune Cell Reengineering, Tumor Targeting, Next-generation Therapies, Anti-cancer Immune Enhancement, Advanced Therapies, Cell Therapy, Oncology, Immune System Augmentation, Biotech Innovation, Patient-specific Treatment
Website
manatherapeutics.com umoja-biopharma.com
Mana Therapeutics logo

About Mana Therapeutics

Mana Therapeutics is a biotechnology startup founded in 2018. The company's mission is to educate immune cells to eliminate cancer, striving for lifelong immunity. With a dedicated team of scientists, physicians, and advocates, Mana Therapeutics is at the forefront of empowering immune cells in the...

Umoja Biopharma logo

About Umoja Biopharma

Umoja Biopharma, founded in 2019, is a pioneering force in the biopharmaceutical arena, with a focus on advancing immunotherapies for cancer treatment. The company is dedicated to enhancing the body's natural defense mechanisms by engineering immune cells directly within the patient, as reflected in...

We will tell you when either one moves

BounceWatch watches Mana Therapeutics and Umoja Biopharma for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Mana Therapeutics and Umoja Biopharma — by email.

Frequently Asked Questions

Mana Therapeutics. Umoja Biopharma — Pioneering advanced immunotherapies to empower the body's innate ability to fight cancer by reengineering immune cells directly within the patient.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Mana Therapeutics has raised $49.50M while Umoja Biopharma has raised $363.00M.
Mana Therapeutics and Umoja Biopharma operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Mana Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Mana Therapeutics on 9 Jun 2026, and Umoja Biopharma on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes